"Digital biomarkers" in preclinical heart failure models - a further step towards improved translational research.

Authors:
Schmidt A; Balitzki J; Grmaca L; Vogel J; Boehme P and 4 more

Journal:
Heart Fail Rev

Publication Year: 2022

DOI:
10.1007/s10741-022-10264-4

PMCID:
PMC9902409

PMID:
36001250

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Heart Fail Rev

Abbreviation: Heart Fail Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breas…
Gao Y; Wang R; Jiang J and 3 more (2023) - Transparency Score: 3/6
Acute advanced aortic stenosis.
Avvedimento M; Angellotti D; Ilardi F and 11 more (2023) - Transparency Score: 3/6
Advance of echocardiography in cardiac amyloidosis.
Liang S; Liu Z; Li Q and 2 more (2023) - Transparency Score: 2/6
Artificial intelligence models in prediction of response to cardiac resynchronization therapy: a sy…
Nazar W; Szymanowicz S; Nazar K and 4 more (2023) - Transparency Score: 3/6
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of…
Rebolledo Del Toro M; Herrera Leaño NM; Barahona-Correa JE and 3 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThe manuscript does not contain clinical studies or patient data. Conflict of interestWithin the last 3 years of beginning the work, the following authors were employees of Bayer AG: Alexander Schmidt, Jakob Balitzki, Ljubica Grmaca, Julia Vogel, Philip Boehme M.D., Katharina Boden, Jörg Hüser PhD, Hubert Truebel M.D., Thomas Mondritzki PhD. Conflict of interest Within the last 3 years of beginning the work, the following authors were employees of Bayer AG: Alexander Schmidt, Jakob Balitzki, Ljubica Grmaca, Julia Vogel, Philip Boehme M.D., Katharina Boden, Jörg Hüser PhD, Hubert Truebel M.D., Thomas Mondritzki PhD."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025